ADC Therapeutics SA
Ticker: 1771910
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 18.63-7.0% | 20.03+27.2% | 15.75-12.9% | 18.09+4.0% | 17.40-3.4% | 18.02+5.8% | 17.03-4.6% | 17.85 |
| Total Income | 18.63-7.0% | 20.03+27.2% | 15.75-12.9% | 18.09+4.0% | 17.40-3.4% | 18.02+5.8% | 17.03-4.6% | 17.85 |
| EXPENSES | ||||||||
| Expenditure | 44.66-3.1% | 46.10-2.7% | 47.40-24.7% | 62.99+22.3% | 51.50-4.7% | 54.03+16.3% | 46.45-10.1% | 51.67 |
| Tax | 0.00 | 0.00 | 0.00-100.0% | 1.25+635.3% | 0.17+88.9% | 0.09-60.9% | 0.23+43.8% | 0.16 |
| PROFIT | ||||||||
| PBT | -16.57+49.7% | -32.97+19.5% | -40.97+26.0% | -55.39-44.1% | -38.44+11.9% | -43.62-22.2% | -35.71+22.0% | -45.76 |
| Net Profit | -16.57+49.7% | -32.97+19.5% | -40.97+27.7% | -56.65-46.8% | -38.60+12.2% | -43.97-20.3% | -36.54+21.6% | -46.61 |
| KEY METRICS | ||||||||
| OPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | -88.90%+11.10pp | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | -0.11+47.6% | -0.21+30.0% | -0.30+40.0% | -0.50-38.9% | -0.36+14.3% | -0.42-10.5% | -0.38+32.1% | -0.56 |
Corporate Events
Board MeetingADCT
202630Jun
Board Meeting
Board of Directors approved one-time retention awards for ce…
SEC Filing ↗ Board MeetingADCT
20261Jun
Board Meeting
Annual General Meeting of shareholders to approve financial …
SEC Filing ↗